Choroidal Neovascularization Market is an ailment, that is distinguished by the formation of new blood vessels that evolve either because of the existence of Vascular Endothelial Growth Factors or because of Age-related Macular Degeneration (AMD). It has been noted that this particular disease is quite prominently occurring in the population with flaws in the inmost stratum of the choroid known as Bruch's membrane. It is linked with the production of new blood vessels in the choroidal layer of eye.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/choroidal-neovascularization-cnv-market/request-sample
The key driving factors responsible for the growth of Choroidal
Neovascularization market :
These blood vessels may suddenly
break into the retina and give rise to disruption as well as sight loss/vision
loss. The key symptoms of this disorder may encompass loss of vision,
metamorphopsia, paracentral or central scotoma, and apparent change in image
size. This disease frequently takes place among the aged group of population
and among people who are suffering from severe myopia. Among all, Fluorescein
Angiography (FA) is the most frequently employed diagnosis technique.
And now days, it has been
observed that the method of spectral domain OCT has occupied the position of
FA, the reason being its attached benefits and highly accurate treatment
provided by it. The studies show that CNV very often originate from posterior
pole lesions and therefore it becomes quite difficult to spot and identify.
Thus, it is very essential to take up an accurate and precise diagnosis in
order to get relief from CNV. Researchers have identified a wide range of
diagnosis methods of CNV along with various treatments.
As far the treatments are
concerned, the prominent ones include angiogenesis inhibitors injection,
photodynamic therapy, laser photocoagulation, low dose radiation therapy as
well as surgery. Among all these mentioned treatments, it is said that
angiogenesis inhibitor injection is the most traditional technique to
administer the development of blood vessels by decreasing the area of fluid
that is just below the retinal pigment epithelium.
The prominent factor that is
playing a major part in raising the Choroidal Neovascularization (CNV) market
share include high rate of increment in CNV affected patients owing to
augmented aged population. In addition, the concerned government authorities
and heath care departments across the globe are taking up various initiatives
for raising awareness among the masses regarding the disease. Plus, they are
offering appropriate diagnosis and treatments at reasonable prices.
This is in turn assisting in
compelling the overall growth of Choroidal Neovascularization (CNV) market. The
only factors that are turning as major hurdles in the market growth include
high lack of awareness among masses especially in the African and Asian regions
regarding various kinds of eye diseases and soaring cost attached with its
treatment.
Additionally, inaccessibility of
better healthcare infrastructure, enhanced facilities and high grade care of
patients are still standing in the mid-way as major challenges in the market
growth. Choroidal Neovascularization (CNV) Market size on the basis of
geography spans North America, Europe, Asia-Pacific, South America, and Middle
East and Africa. As far as the geography is concerned, Asia Pacific is
currently leading the market and it is anticipated that it will rise with a robust
CAGR in the next couple of years particularly in the countries like China, and
India.
On the other hand, North America
is also emerging in the Choroidal Neovascularization (CNV) market owing to the
large number of aged population present in the particular region. It is noted
that the region is highly affected by this disease. The key players operating
in the Choroidal Neovascularization (CNV) market include Bayer AG, Resolvyx
Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd, Valeant Pharmaceuticals International
Inc., and Chengdu Kanghong Biotech Co. Ltd.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/choroidal-neovascularization-cnv-market
No comments:
Post a Comment